Prophylaxis With a Middle East Respiratory Syndrome Coronavirus (MERS-CoV)–Specific Human Monoclonal Antibody Protects Rabbits From MERS-CoV Infection

With >1600 documented human infections with Middle East respiratory syndrome coronavirus (MERS-CoV) and a case fatality rate of approximately 36%, medical countermeasures are needed to prevent and limit the disease. We examined the in vivo efficacy of the human monoclonal antibody m336, which has...

Descripción completa

Detalles Bibliográficos
Autores principales: Houser, Katherine V., Gretebeck, Lisa, Ying, Tianlei, Wang, Yanping, Vogel, Leatrice, Lamirande, Elaine W., Bock, Kevin W., Moore, Ian N., Dimitrov, Dimiter S., Subbarao, Kanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2016
Materias:
Major Articles and Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837915/
https://www.ncbi.nlm.nih.gov/pubmed/26941283
http://dx.doi.org/10.1093/infdis/jiw080

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4837915/
https://www.ncbi.nlm.nih.gov/pubmed/26941283
http://dx.doi.org/10.1093/infdis/jiw080

Ejemplares similares